Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026)
Natera's (NTRA) quarterly Non-Current Deferred Tax Liability came in at $701000.0 in Q2 2026, little changed quarter-over-quarter from $701000.0 in Q1 2026.
Powered by 
Analysis
Natera (NTRA) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends
Natera (NTRA) has reported Non-Current Deferred Tax Liability for 2 consecutive years, with $701000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $701000.0; the trailing twelve-month figure through Jun 2026 stood at $701000.0 (changed N/A YoY), and the FY2025 full-year result was $701000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability held at $701000.0 in Q2 2026 per NTRA's latest filing, from $701000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $701000.0 in Q4 2025 and bottomed at $701000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 701,000.00 |
| Mar 31, 2026 | 701,000.00 |
| Dec 31, 2025 | 701,000.00 |